NCT05741749 Immediate Implant Placement in the Posterior Region Combining Sealing Socket Abutment and Peri-implant Socket Filling.
| NCT ID | NCT05741749 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Liege |
| Condition | Dental Implantation |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2022-10-01 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2022-10-01 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary endpoint of this study is to compare the soft tissue contour changes after immediate implant placement combined to peri-implant socket filling with a sealing socket abutment (SSA) versus a standard healing abutment. The hypothesis is that the SSA better preserves the alveolar ridge profile in the cervical region compared to a conventional healing abutment. The secondary objectives aim to evaluate 3D hard tissue changes, peri-implant bone remodeling, soft tissue health, esthetic outcomes and the patients related outcome measures.
Eligibility Criteria
Inclusion Criteria: * Good general health (ASA I/II), * More than 18 years old, * Smoker \< 10c/day, one hopeless tooth, * Healthy periodontal condition, * Presence of at least 2 mm of keratinized gingiva * Intact buccal bone wall * Adequate plaque control (FMPS ≤ 25%) * Adequate bone quantity allowing an immediate implant procedure (apical bone height of at - Least 5 mm or presence of interradicular septum) * Written consent provided Exclusion Criteria: * Auto-immune disease or immunocompromised patients * Uncontrolled diabetes * Use of steroids or biphosphonates * Local or systemic infection (medical treatment needed prior to entrance to the study) * Pregnancy or breastfeeding * Alcoholism or chronically drug abuse * Bone availability requiring an angulated abutment * Untreated local inflammation * Cyst * Mucosal disease or oral lesions * Local irradiation therapy * Oral communication with sinus after the extraction
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05741749 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Dental Implantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05741749 currently recruiting?
Yes, NCT05741749 is actively recruiting participants. Contact the research team at bruno.decarvalho@chuliege.be for enrollment information.
Where is the NCT05741749 trial being conducted?
This trial is being conducted at Liège, Belgium.
Who is sponsoring the NCT05741749 clinical trial?
NCT05741749 is sponsored by University of Liege. The trial plans to enroll 30 participants.